River Front Investment Group, LLC Biogen Inc. Transaction History

River Front Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$282.99 - $369.05 $264,595 - $345,061	-935 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $21,497 - $34,420	83 Added 9.74%	935 $324,000
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $7,774 - $9,108	32 Added 3.9%	852 $238,000
Q4 2020 Feb 03, 2021	BUY	$236.26 - $355.63 $193,733 - $291,616	820 New	820 $201,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of River Front Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on River Front Investment Group, LLC with notifications on news.